All VCS sites will be conducting temperature checks for all patients and visitors at entrances. For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Telemedicine visits are now available for routine office visits. VCS is keeping updated on current state and local guidance for the Covid vaccine rollout plan. FOR THE LATEST UP TO DATE INFORMATION, ALERTS, VACCINE INFORMATION AND CANCELLATIONS PLEASE CLICK HERE

Archive

Post Archive: Physicians

Dr. Alex Spira quoted in announcement from Mirati Theraputics: Progress Of Lead Programs And Updated Positive Clinical Trial Results For Immuno-Oncology Combination Trials

April 26, 2018
Read More

New clinical data for chemotherapy drug administered in metastatic breast cancer co-presented by Dr. Amy Irwin of Virginia Cancer Specialists

March 15, 2018
Read More

Virginia Cancer Specialists first patient successfully completes Cycle 1 of Treatment with PCM-075 combination with Low Dose Cytarabine (LDAC) AML Trial

March 6, 2018
Read More

Alex Spira, MD Co-Author of collaborative study on Immunotherapy guidelines to guide clinicians and patients

February 15, 2018
Read More

Dr. Robert Reid of Virginia Cancer Specialists presents data on an important Study for Prostate Cancer

February 7, 2018
Read More

Virginia Cancer Specialists enrolls fist patient in Phase 1b/2 Clinical Trial of PCM-075 for Acute Myeloid Leukemia (AML)

February 7, 2018
Read More

Northern Virginia 2018 Thoracic Oncology Symposium, CME Program - March 10th 2018

January 30, 2018
Read More

Boy Scout supports cancer patients with a very special Eagle Scout project

January 23, 2018
Read More

From angst to analytics: lessons learned from an oncology care model internal pilot. Amit Sarma, MD

January 9, 2018
Read More

VCS Enrolls First Patient in Phase 1/2 Clinical Trial of BION-1301-Novel Anti-APRIL Antibody, Treatment of Multiple Myeloma

December 28, 2017
Read More